Introduction {#Sec1}
============

One of the most serious complications of major trauma is the sequential dysfunction of vital organs, mostly associated with posttraumatic sepsis. IL-17 has been linked to the severity of inflammation in tissues. It initiates the production of other pro-inflammatory mediators resulting in an influx of neutrophils.

Objectives {#Sec2}
==========

To investigate whether the level of IL17A at the day of admission could predict the occurrence of sepsis in polytrauma patients or not.

Methods {#Sec3}
=======

A prospective cohort study in polytrauma patients. 100 consecutive adult polytrauma patients were included. Serum level of IL-17A was measured at the day of admission to the intensive care unit (ICU). Patients were screened for the development of sepsis. Other data collection included; demographic data Abbreviated Injury Scale (AIS), APACHE II score, acute kidney injury assessed by RIFLE criteria, acute respiratory distress syndrome (ARDS), duration of mechanical ventilation, ICU length of stay & 28-day mortality.

Results {#Sec4}
=======

Out of 100 patients 47 (47%) developed sepsis. Serum level of IL-17A was significantly higher in the group of patients who developed sepsis compared to the non-septic group (p-value 0.004). The optimum cut-off value of serum IL-17A for sepsis prediction in polytrauma patients was ≥ 53.8 pg/ml. This cut-off value had a sensitivity of 60.7 % & a specificity of 76.4%, area under the curve (AUC) was 0.687 (95% CI 0.573-0.802), (p value 0.004), as shown in Figure 1. High serum level of IL17-A was associated with increased 28 days ICU mortality as shown in Figure 2 (p value of 0.06).

Neither ARDS nor Multiple Organ Dysfunction Score (MODS) was associated with increased IL-17A serum level.

Conclusions {#Sec5}
===========

IL-17A is a potential predictor of sepsis occurrence in patients with polytrauma.
